Search - tctmd.com

Displaying 981 - 1000 of 1165

Sort: Relevancy | Date

News Conference News ESC 2016

Optimal Approach for BP Lowering Debated Amid New J-Curve Signals in Stable CAD

Todd Neale

September 09, 2016

News Daily News

心血管药物发展趋势存在渠道问题和可能性

Caitlin E. Cox

September 08, 2016

News Daily News

Trends in Cardiovascular Drug Development Speak to Pipeline Problems and Possibilities

Caitlin E. Cox

September 08, 2016

News Opinion Editor's Corner ESC 2016

My Takeaways From ESC 2016: Eye-Rolling, Disappointments, and a Sobering Comeuppance

Shelley Wood

September 08, 2016

News Daily News

Short-term DAPT Not Necessarily the Best Option for All, Especially After Complex PCI

Yael L. Maxwell

September 02, 2016

News Conference News ESC 2016

STICH Analysis by Age Shows Benefit of CABG in Ischemic Heart Failure Across the Decades

Shelley Wood

August 29, 2016

News Conference News ESC 2016

ICDs Do Not Reduce Mortality in Patients With HF Not Caused by Coronary Artery Disease: DANISH

Michael O'Riordan

August 28, 2016

News Conference News ESC 2016

Another Meeting, Another Mesenchymal Stem Cell Study (or Two), With Mixed Results

Shelley Wood

August 28, 2016

News Conference News ESC 2016

N-Acetylcysteine for Myocardial Salvage in STEMI? NACIAM Trial Treads Where Many Have Flopped Before

Shelley Wood

August 28, 2016

News Daily News

‘Shotgunning’ Approach Appears to Knock Down Readmissions After PCI

Todd Neale

August 25, 2016

News Daily News

Increased Risk of In-Hospital Complications, Including Mortality, Among A-fib Patients Undergoing PCI

Michael O'Riordan

August 24, 2016

News Daily News

Beta-Blockers Not Beneficial After PCI for Stable Angina

Michael O'Riordan

August 17, 2016

News Daily News

Underuse of Medical Therapy Linked With Increased Adverse Events in Very Elderly

Michael O'Riordan

July 21, 2016

News Opinion Fellow Talk

Acute Myocardial Infarction with Cardiogenic Shock: Time for a Paradigm Shift in Care

Rahul Sharma, MD

July 21, 2016

News Daily News

Time for Niacin to Be ‘Relegated to Medical History’ as HPS2-THRIVE Analysis Confirms Drug’s Failings

Michael O'Riordan

July 12, 2016

News Daily News

AHA Advises Physicians to Monitor Medications That Might Cause or Worsen Heart Failure

Michael H. Wilson

July 12, 2016

News Daily News

Aspirin as Standalone Stroke Protection Still Overused for Patients With A-fib

Todd Neale

June 27, 2016

News Daily News

Black Individuals Have Less A-fib, but When They Do, the Consequences Are More Dire

Michael O'Riordan

June 24, 2016

News Daily News

利拉鲁肽超越 FDA 安全预期，可降低心血管疾病的死亡率：LEADER

Michael O'Riordan

June 14, 2016

News Daily News

Broader, Primary Prevention Role for High-Sensitivity Troponin Tests Suggested by ARIC Analysis

Shelley Wood

June 10, 2016

Advertisement

Optimal Approach for BP Lowering Debated Amid New J-Curve Signals in Stable CAD

心血管药物发展趋势存在渠道问题和可能性

Trends in Cardiovascular Drug Development Speak to Pipeline Problems and Possibilities

My Takeaways From ESC 2016: Eye-Rolling, Disappointments, and a Sobering Comeuppance

Short-term DAPT Not Necessarily the Best Option for All, Especially After Complex PCI

STICH Analysis by Age Shows Benefit of CABG in Ischemic Heart Failure Across the Decades

ICDs Do Not Reduce Mortality in Patients With HF Not Caused by Coronary Artery Disease: DANISH

Another Meeting, Another Mesenchymal Stem Cell Study (or Two), With Mixed Results

N-Acetylcysteine for Myocardial Salvage in STEMI? NACIAM Trial Treads Where Many Have Flopped Before

‘Shotgunning’ Approach Appears to Knock Down Readmissions After PCI

Increased Risk of In-Hospital Complications, Including Mortality, Among A-fib Patients Undergoing PCI

Beta-Blockers Not Beneficial After PCI for Stable Angina

Underuse of Medical Therapy Linked With Increased Adverse Events in Very Elderly

Acute Myocardial Infarction with Cardiogenic Shock: Time for a Paradigm Shift in Care

Time for Niacin to Be ‘Relegated to Medical History’ as HPS2-THRIVE Analysis Confirms Drug’s Failings

AHA Advises Physicians to Monitor Medications That Might Cause or Worsen Heart Failure

Aspirin as Standalone Stroke Protection Still Overused for Patients With A-fib

Black Individuals Have Less A-fib, but When They Do, the Consequences Are More Dire

利拉鲁肽超越 FDA 安全预期，可降低心血管疾病的死亡率：LEADER

Broader, Primary Prevention Role for High-Sensitivity Troponin Tests Suggested by ARIC Analysis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content